Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for LMAT

Stock Name	LeMaitre Vascular Inc
Ticker	LMAT(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US5255582018
LEI	549300FZUBUB7MHY8R17

Show aggregate LMAT holdings

News associated with LMAT

LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives Average Rating of “Hold” from Analysts: Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have been assigned an average recommendation of “Hold” from the five analysts that are covering the company, MarketBeat Ratings reports. Three analysts have rated the stock with a hold recommendation and two have issued a buy recommendation on the company. The average 12-month price target […] - 2025-09-15 04:46:52
Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) PT at $97.60: Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have been given an average recommendation of “Hold” by the five analysts that are covering the stock, MarketBeat reports. Three analysts have rated the stock with a hold recommendation and two have given a buy recommendation to the company. The average 1 year price target […] - 2025-09-15 04:46:48
Peek Under The Hood: SDVY Has 10% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-09-11 07:55:13
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Receives $98.00 Consensus Price Target from Analysts: LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) has been given an average recommendation of “Moderate Buy” by the six brokerages that are covering the stock, Marketbeat reports. Three equities research analysts have rated the stock with a hold rating and three have given a buy rating to the company. The average 1 year target […] - 2025-08-19 02:16:55
LeMaitre Vascular (NASDAQ:LMAT) Upgraded by Barrington Research to Outperform Rating: LeMaitre Vascular (NASDAQ:LMAT – Get Free Report) was upgraded by stock analysts at Barrington Research from a “market perform” rating to an “outperform” rating in a research report issued on Wednesday, MarketBeat.com reports. The brokerage presently has a $95.00 price objective on the medical instruments supplier’s stock. Barrington Research’s target price suggests a potential upside […] - 2025-08-08 02:40:48
LeMaitre Vascular Breaks Above 200-Day Moving Average - Bullish for LMAT: In trading on Wednesday, shares of LeMaitre Vascular Inc (Symbol: LMAT) crossed above their 200 day moving average of $89.93, changing hands as high as $96.14 per share. LeMaitre Vascular Inc shares are currently trading up about 11% on the day. The chart below shows the one y - 2025-08-06 12:48:00
LeMaitre (LMAT) Q2 Revenue Jumps 15%: Key PointsGAAP earnings per share were $0.60 for Q2 2025, beating analyst expectations of $0.57. - 2025-08-06 02:09:32
Lindenwold Advisors INC Sells 330 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT): Lindenwold Advisors INC lowered its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 11.9% in the first quarter, Holdings Channel reports. The institutional investor owned 2,450 shares of the medical instruments supplier’s stock after selling 330 shares during the period. Lindenwold Advisors INC’s holdings in LeMaitre Vascular were worth $206,000 as […] - 2025-08-01 04:22:55
Alps Advisors Inc. Invests $354,000 in LeMaitre Vascular, Inc. (NASDAQ:LMAT): Alps Advisors Inc. purchased a new position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 4,220 shares of the medical instruments supplier’s stock, valued at approximately $354,000. Several other large investors have also modified […] - 2025-07-17 05:28:55
Envestnet Asset Management Inc. Grows Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT): Envestnet Asset Management Inc. raised its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 9.9% in the first quarter, according to its most recent 13F filing with the SEC. The fund owned 285,109 shares of the medical instruments supplier’s stock after buying an additional 25,680 shares during the period. Envestnet Asset […] - 2025-07-16 04:50:54
New York State Teachers Retirement System Has $670,000 Stock Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT): New York State Teachers Retirement System lowered its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 2.4% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 7,989 shares of the medical instruments supplier’s stock after selling 200 shares during […] - 2025-07-11 05:15:00
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Teacher Retirement System of Texas: Teacher Retirement System of Texas lowered its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 73.9% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 26,534 shares of the medical instruments supplier’s stock after selling 75,317 shares during the period. […] - 2025-07-10 05:14:10
State of Alaska Department of Revenue Reduces Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT): State of Alaska Department of Revenue lowered its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 2.3% in the 1st quarter, HoldingsChannel reports. The fund owned 11,337 shares of the medical instruments supplier’s stock after selling 262 shares during the period. State of Alaska Department of Revenue’s holdings in LeMaitre Vascular were worth […] - 2025-06-27 05:06:50
Farther Finance Advisors LLC Decreases Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT): Farther Finance Advisors LLC cut its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 20.5% during the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 783 shares of the medical instruments supplier’s stock after selling 202 shares during the quarter. Farther Finance […] - 2025-06-23 04:26:50
Fifth Third Bancorp Increases Stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT): Fifth Third Bancorp grew its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 2.3% in the first quarter, HoldingsChannel.com reports. The firm owned 10,903 shares of the medical instruments supplier’s stock after buying an additional 246 shares during the quarter. Fifth Third Bancorp’s holdings in LeMaitre Vascular were worth $915,000 at […] - 2025-06-17 04:51:01
Peek Under The Hood: SDVY Has 12% Upside: Looking at the underlying holdings of the ETFs in our coverage universe at ETF Channel, we have compared the trading price of each holding against the average analyst 12-month forward target price, and computed the weighted average implied analyst target price for the ETF itself. - 2025-06-12 08:30:38
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Two Sigma Advisers LP: Two Sigma Advisers LP trimmed its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 28.2% during the fourth quarter, Holdings Channel.com reports. The fund owned 18,300 shares of the medical instruments supplier’s stock after selling 7,200 shares during the period. Two Sigma Advisers LP’s holdings in LeMaitre Vascular were worth $1,686,000 at the […] - 2025-05-30 05:31:03
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by D. E. Shaw & Co. Inc.: D. E. Shaw & Co. Inc. trimmed its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 62.7% in the fourth quarter, HoldingsChannel reports. The firm owned 18,571 shares of the medical instruments supplier’s stock after selling 31,233 shares during the period. D. E. Shaw & Co. Inc.’s holdings in LeMaitre Vascular […] - 2025-05-22 04:48:46
Captrust Financial Advisors Has $507,000 Holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT): Captrust Financial Advisors decreased its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 11.4% during the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 5,500 shares of the medical instruments supplier’s stock after selling 706 shares during the period. Captrust Financial Advisors’ holdings […] - 2025-05-19 04:52:56
Ex-Dividend Reminder: Select Medical Holdings, LeMaitre Vascular and Selective Insurance Group: Looking at the universe of stocks we cover at Dividend Channel, on 5/15/25, Select Medical Holdings Corp (Symbol: SEM), LeMaitre Vascular Inc (Symbol: LMAT), and Selective Insurance Group Inc (Symbol: SIGI) will all trade ex-dividend for their respective upcoming dividends. Sele - 2025-05-13 12:47:45
Hsbc Holdings PLC Buys 1,170 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT): Hsbc Holdings PLC grew its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 43.5% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 3,861 shares of the medical instruments supplier’s stock after purchasing an additional 1,170 shares during the quarter. […] - 2025-05-09 05:38:59
LeMaitre Vascular (NASDAQ:LMAT) Trading 4.2% Higher After Dividend Announcement: LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) shares shot up 4.2% during trading on Monday following a dividend announcement from the company. The company traded as high as $80.61 and last traded at $82.04. 19,169 shares were traded during trading, a decline of 88% from the average session volume of 162,392 shares. The stock […] - 2025-05-07 02:21:01
Brokerages Set LeMaitre Vascular, Inc. (NASDAQ:LMAT) Price Target at $98.14: Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Get Free Report) have received an average rating of “Moderate Buy” from the eight analysts that are covering the stock, MarketBeat Ratings reports. Four equities research analysts have rated the stock with a hold recommendation, three have issued a buy recommendation and one has issued a strong buy […] - 2025-04-30 02:34:48
Wells Fargo & Company MN Purchases 2,274 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT): Wells Fargo & Company MN boosted its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 8.8% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 28,153 shares of the medical instruments supplier’s stock after acquiring an additional 2,274 shares during the quarter. Wells Fargo & Company MN’s holdings in LeMaitre […] - 2025-04-25 04:26:54
Alliancebernstein L.P. Purchases 1,287 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT): Alliancebernstein L.P. grew its holdings in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 6.0% during the 4th quarter, HoldingsChannel reports. The firm owned 22,584 shares of the medical instruments supplier’s stock after acquiring an additional 1,287 shares during the quarter. Alliancebernstein L.P.’s holdings in LeMaitre Vascular were worth $2,081,000 as of its most recent […] - 2025-04-17 04:30:59
Franklin Resources Inc. Grows Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT): Franklin Resources Inc. grew its stake in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 8.2% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 13,678 shares of the medical instruments supplier’s stock after buying an additional 1,032 shares […] - 2025-04-15 04:56:59
Geode Capital Management LLC Purchases 7,737 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT): Geode Capital Management LLC lifted its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 1.4% during the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund owned 550,260 shares of the medical instruments supplier’s stock after buying an additional 7,737 shares during the […] - 2025-04-14 05:42:55
Envestnet Asset Management Inc. Increases Stock Position in LeMaitre Vascular, Inc. (NASDAQ:LMAT): Envestnet Asset Management Inc. lifted its position in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 7.0% during the fourth quarter, Holdings Channel reports. The firm owned 259,429 shares of the medical instruments supplier’s stock after acquiring an additional 16,886 shares during the period. Envestnet Asset Management Inc.’s holdings in LeMaitre Vascular were […] - 2025-04-14 04:48:50
LeMaitre Vascular, Inc. (NASDAQ:LMAT) Shares Sold by Trexquant Investment LP: Trexquant Investment LP cut its stake in shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 3.6% in the fourth quarter, according to its most recent disclosure with the SEC. The firm owned 6,066 shares of the medical instruments supplier’s stock after selling 224 shares during the period. Trexquant Investment LP’s holdings in LeMaitre […] - 2025-04-13 07:09:04
Commonwealth Equity Services LLC Sells 2,171 Shares of LeMaitre Vascular, Inc. (NASDAQ:LMAT): Commonwealth Equity Services LLC trimmed its position in LeMaitre Vascular, Inc. (NASDAQ:LMAT – Free Report) by 21.8% during the fourth quarter, Holdings Channel reports. The firm owned 7,794 shares of the medical instruments supplier’s stock after selling 2,171 shares during the quarter. Commonwealth Equity Services LLC’s holdings in LeMaitre Vascular were worth $718,000 as of […] - 2025-04-03 04:20:47

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc LMAT holdings

Date	Number of LMAT Shares Held	Base Market Value of LMAT Shares	Local Market Value of LMAT Shares	Change in LMAT Shares Held	Change in LMAT Base Value	Current Price per LMAT Share Held	Previous Price per LMAT Share Held
2025-12-24 (Wednesday)	1,835	USD 154,764	USD 154,764	0	USD 679	USD 84.3401	USD 83.97
2025-12-23 (Tuesday)	1,835	USD 154,085	USD 154,085	-6	USD -1,498	USD 83.97	USD 84.51
2025-12-22 (Monday)	1,841	USD 155,583	USD 155,583	0	USD -828	USD 84.51	USD 84.9598
2025-12-19 (Friday)	1,841	USD 156,411	USD 156,411	0	USD -571	USD 84.9598	USD 85.27
2025-12-18 (Thursday)	1,841	USD 156,982	USD 156,982	0	USD 617	USD 85.27	USD 84.9348
2025-12-17 (Wednesday)	1,841	USD 156,365	USD 156,365	0	USD 2,807	USD 84.9348	USD 83.4101
2025-12-16 (Tuesday)	1,841	USD 153,558	USD 153,558	0	USD 1,178	USD 83.4101	USD 82.7702
2025-12-15 (Monday)	1,841	USD 152,380	USD 152,380	0	USD -2,264	USD 82.7702	USD 84
2025-12-12 (Friday)	1,841	USD 154,644	USD 154,644	0	USD 1,178	USD 84	USD 83.3601
2025-12-11 (Thursday)	1,841	USD 153,466	USD 153,466	0	USD -552	USD 83.3601	USD 83.66
2025-12-10 (Wednesday)	1,841	USD 154,018	USD 154,018	0	USD 1,491	USD 83.66	USD 82.8501
2025-12-09 (Tuesday)	1,841	USD 152,527	USD 152,527	0	USD -147	USD 82.8501	USD 82.9299

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of LMAT by Blackrock for IE00B3VWM098

Show aggregate share trades of LMAT

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-12-23 SELL -6 84.690 83.325 83.462 USD -501 88.58 Profit of 31 on sale
2025-12-03 SELL -30 85.020 81.849 82.166 USD -2,465 88.88 Profit of 201 on sale
2025-12-02 BUY 12 83.910 81.600 81.831 USD 982 88.90
2025-11-25 SELL -18 86.580 82.710 83.097 USD -1,496 89.04 Profit of 107 on sale
2025-11-24 SELL -18 89.425 84.040 84.579 USD -1,522 89.06 Profit of 81 on sale
2025-11-17 SELL -66 88.355 86.690 86.856 USD -5,733 89.13 Profit of 150 on sale
2025-11-12 SELL -6 91.960 89.910 90.115 USD -541 89.12 Loss of -6 on sale
2025-11-06 SELL -6 88.000 85.130 85.417 USD -513 89.16 Profit of 22 on sale
2025-11-05 SELL -60 87.800 85.900 86.090 USD -5,165 89.17 Profit of 185 on sale
2025-11-04 SELL -12 90.000 86.580 86.922 USD -1,043 89.18 Profit of 27 on sale
2025-11-03 SELL -12 87.200 84.410 84.689 USD -1,016 89.19 Profit of 54 on sale
2025-10-28 BUY 18 89.540 90.170 90.107 USD 1,622 89.21
2025-10-24 SELL -6 89.210 89.560 89.525 USD -537 89.20 Loss of -2 on sale
2025-10-15 BUY 36 87.260 87.950 87.881 USD 3,164 89.24
2025-10-02 BUY 6 86.870 87.420 87.365 USD 524 89.27
2025-09-30 BUY 12 87.510 88.080 88.023 USD 1,056 89.29
2025-08-21 SELL -6 96.450 97.040 96.981 USD -582 89.31 Loss of -46 on sale
2025-07-31 BUY 18 81.240 81.940 81.870 USD 1,474 89.32
2025-06-30 SELL -12 83.050 83.720 83.653 USD -1,004 90.17 Profit of 78 on sale
2025-06-25 SELL -6 84.540 85.390 85.305 USD -512 90.32 Profit of 30 on sale
2025-06-20 SELL -12 81.780 82.530 82.455 USD -989 90.47 Profit of 96 on sale
2025-05-23 BUY 6 81.400 81.470 81.463 USD 489 91.85
2025-05-19 SELL -6 85.960 86.270 86.239 USD -517 92.16 Profit of 36 on sale
2025-05-15 SELL -18 83.300 83.910 83.849 USD -1,509 92.30 Profit of 152 on sale
2025-05-12 SELL -6 82.460 83.950 83.801 USD -503 92.55 Profit of 53 on sale
2025-05-09 SELL -6 80.260 82.300 82.096 USD -493 92.66 Profit of 63 on sale
2025-04-30 SELL -6 90.740 91.850 91.739 USD -550 93.27 Profit of 9 on sale
2025-04-24 SELL -12 91.760 92.410 92.345 USD -1,108 93.33 Profit of 12 on sale
2025-04-17 SELL -6 86.280 86.990 86.919 USD -522 93.68 Profit of 41 on sale
2025-04-15 SELL -18 84.630 84.730 84.720 USD -1,525 93.88 Profit of 165 on sale
2025-04-14 SELL -18 83.780 84.500 84.428 USD -1,520 93.99 Profit of 172 on sale
2025-04-09 SELL -24 83.900 85.440 85.286 USD -2,047 94.37 Profit of 218 on sale
2025-04-07 SELL -42 79.390 82.400 82.099 USD -3,448 94.73 Profit of 530 on sale
2025-04-04 SELL -60 79.780 81.340 81.184 USD -4,871 94.90 Profit of 823 on sale
2025-03-31 BUY 6 83.900 84.700 84.620 USD 508 95.25
2025-03-19 SELL -12 84.820 86.680 86.494 USD -1,038 96.39 Profit of 119 on sale
2025-03-14 SELL -36 81.910 82.290 82.252 USD -2,961 96.91 Profit of 528 on sale
2025-03-13 SELL -12 78.820 82.420 82.060 USD -985 97.16 Profit of 181 on sale
2025-03-12 SELL -204 81.520 84.460 84.166 USD -17,170 97.38 Profit of 2,697 on sale
2025-03-07 SELL -12 81.370 82.270 82.180 USD -986 98.08 Profit of 191 on sale
2025-03-06 SELL -18 82.490 86.590 86.180 USD -1,551 98.32 Profit of 218 on sale
2025-03-03 SELL -6 92.160 94.520 94.284 USD -566 98.72 Profit of 27 on sale
2025-02-28 SELL -36 91.850 93.170 93.038 USD -3,349 98.83 Profit of 208 on sale
2025-02-26 SELL -6 103.050 105.550 105.300 USD -632 98.74 Loss of -39 on sale
2025-02-25 SELL -18 104.000 104.320 104.288 USD -1,877 98.65 Loss of -101 on sale
2025-02-18 BUY 30 100.740 100.920 100.902 USD 3,027 98.32
2025-02-13 BUY 6 96.990 98.060 97.953 USD 588 98.33
2025-02-12 BUY 6 96.320 97.810 97.661 USD 586 98.37
2025-02-11 BUY 18 96.940 101.770 101.287 USD 1,823 98.40
2025-02-06 BUY 54 99.830 99.830 99.830 USD 5,391 98.38
2025-01-27 BUY 6 99.060 99.260 99.240 USD 595 98.36
2024-12-30 BUY 30 92.950 94.210 94.084 USD 2,823 98.84
2024-12-06 BUY 24 101.120 103.290 103.073 USD 2,474 98.80
2024-12-05 BUY 6 102.480 105.000 104.748 USD 628 98.67
2024-12-04 BUY 30 104.970 106.700 106.527 USD 3,196 98.45
2024-11-29 BUY 30 106.990 107.230 107.206 USD 3,216 97.56
2024-11-27 BUY 24 105.800 106.600 106.520 USD 2,556 96.85
2024-11-26 BUY 6 105.430 107.860 107.617 USD 646 96.46
2024-11-21 BUY 30 105.870 106.990 106.878 USD 3,206 94.80
2024-11-20 BUY 18 103.440 104.110 104.043 USD 1,873 94.32
2024-11-18 BUY 72 103.550 104.610 104.504 USD 7,524 93.15
2024-11-12 BUY 48 103.260 105.780 105.528 USD 5,065 92.48
2024-11-08 BUY 30 104.250 104.810 104.754 USD 3,143 91.64
2024-11-07 BUY 90 101.070 103.290 103.068 USD 9,276 90.91
2024-11-06 BUY 12 101.710 103.960 103.735 USD 1,245 90.01
2024-10-31 BUY 6 88.390 89.340 89.245 USD 535 87.73
Market high and low price is on the date.

Date	Action	Quantity	Market High	Market Low	Likely Trade Price	Likely Trade Value (Profit/Loss)	Average Price previous trades
2025-12-23	SELL	-6	84.690	83.325	83.462	USD -501	88.58 Profit of 31 on sale
2025-12-03	SELL	-30	85.020	81.849	82.166	USD -2,465	88.88 Profit of 201 on sale
2025-12-02	BUY	12	83.910	81.600	81.831	USD 982	88.90
2025-11-25	SELL	-18	86.580	82.710	83.097	USD -1,496	89.04 Profit of 107 on sale
2025-11-24	SELL	-18	89.425	84.040	84.579	USD -1,522	89.06 Profit of 81 on sale
2025-11-17	SELL	-66	88.355	86.690	86.856	USD -5,733	89.13 Profit of 150 on sale
2025-11-12	SELL	-6	91.960	89.910	90.115	USD -541	89.12 Loss of -6 on sale
2025-11-06	SELL	-6	88.000	85.130	85.417	USD -513	89.16 Profit of 22 on sale
2025-11-05	SELL	-60	87.800	85.900	86.090	USD -5,165	89.17 Profit of 185 on sale
2025-11-04	SELL	-12	90.000	86.580	86.922	USD -1,043	89.18 Profit of 27 on sale
2025-11-03	SELL	-12	87.200	84.410	84.689	USD -1,016	89.19 Profit of 54 on sale
2025-10-28	BUY	18	89.540	90.170	90.107	USD 1,622	89.21
2025-10-24	SELL	-6	89.210	89.560	89.525	USD -537	89.20 Loss of -2 on sale
2025-10-15	BUY	36	87.260	87.950	87.881	USD 3,164	89.24
2025-10-02	BUY	6	86.870	87.420	87.365	USD 524	89.27
2025-09-30	BUY	12	87.510	88.080	88.023	USD 1,056	89.29
2025-08-21	SELL	-6	96.450	97.040	96.981	USD -582	89.31 Loss of -46 on sale
2025-07-31	BUY	18	81.240	81.940	81.870	USD 1,474	89.32
2025-06-30	SELL	-12	83.050	83.720	83.653	USD -1,004	90.17 Profit of 78 on sale
2025-06-25	SELL	-6	84.540	85.390	85.305	USD -512	90.32 Profit of 30 on sale
2025-06-20	SELL	-12	81.780	82.530	82.455	USD -989	90.47 Profit of 96 on sale
2025-05-23	BUY	6	81.400	81.470	81.463	USD 489	91.85
2025-05-19	SELL	-6	85.960	86.270	86.239	USD -517	92.16 Profit of 36 on sale
2025-05-15	SELL	-18	83.300	83.910	83.849	USD -1,509	92.30 Profit of 152 on sale
2025-05-12	SELL	-6	82.460	83.950	83.801	USD -503	92.55 Profit of 53 on sale
2025-05-09	SELL	-6	80.260	82.300	82.096	USD -493	92.66 Profit of 63 on sale
2025-04-30	SELL	-6	90.740	91.850	91.739	USD -550	93.27 Profit of 9 on sale
2025-04-24	SELL	-12	91.760	92.410	92.345	USD -1,108	93.33 Profit of 12 on sale
2025-04-17	SELL	-6	86.280	86.990	86.919	USD -522	93.68 Profit of 41 on sale
2025-04-15	SELL	-18	84.630	84.730	84.720	USD -1,525	93.88 Profit of 165 on sale
2025-04-14	SELL	-18	83.780	84.500	84.428	USD -1,520	93.99 Profit of 172 on sale
2025-04-09	SELL	-24	83.900	85.440	85.286	USD -2,047	94.37 Profit of 218 on sale
2025-04-07	SELL	-42	79.390	82.400	82.099	USD -3,448	94.73 Profit of 530 on sale
2025-04-04	SELL	-60	79.780	81.340	81.184	USD -4,871	94.90 Profit of 823 on sale
2025-03-31	BUY	6	83.900	84.700	84.620	USD 508	95.25
2025-03-19	SELL	-12	84.820	86.680	86.494	USD -1,038	96.39 Profit of 119 on sale
2025-03-14	SELL	-36	81.910	82.290	82.252	USD -2,961	96.91 Profit of 528 on sale
2025-03-13	SELL	-12	78.820	82.420	82.060	USD -985	97.16 Profit of 181 on sale
2025-03-12	SELL	-204	81.520	84.460	84.166	USD -17,170	97.38 Profit of 2,697 on sale
2025-03-07	SELL	-12	81.370	82.270	82.180	USD -986	98.08 Profit of 191 on sale
2025-03-06	SELL	-18	82.490	86.590	86.180	USD -1,551	98.32 Profit of 218 on sale
2025-03-03	SELL	-6	92.160	94.520	94.284	USD -566	98.72 Profit of 27 on sale
2025-02-28	SELL	-36	91.850	93.170	93.038	USD -3,349	98.83 Profit of 208 on sale
2025-02-26	SELL	-6	103.050	105.550	105.300	USD -632	98.74 Loss of -39 on sale
2025-02-25	SELL	-18	104.000	104.320	104.288	USD -1,877	98.65 Loss of -101 on sale
2025-02-18	BUY	30	100.740	100.920	100.902	USD 3,027	98.32
2025-02-13	BUY	6	96.990	98.060	97.953	USD 588	98.33
2025-02-12	BUY	6	96.320	97.810	97.661	USD 586	98.37
2025-02-11	BUY	18	96.940	101.770	101.287	USD 1,823	98.40
2025-02-06	BUY	54	99.830	99.830	99.830	USD 5,391	98.38
2025-01-27	BUY	6	99.060	99.260	99.240	USD 595	98.36
2024-12-30	BUY	30	92.950	94.210	94.084	USD 2,823	98.84
2024-12-06	BUY	24	101.120	103.290	103.073	USD 2,474	98.80
2024-12-05	BUY	6	102.480	105.000	104.748	USD 628	98.67
2024-12-04	BUY	30	104.970	106.700	106.527	USD 3,196	98.45
2024-11-29	BUY	30	106.990	107.230	107.206	USD 3,216	97.56
2024-11-27	BUY	24	105.800	106.600	106.520	USD 2,556	96.85
2024-11-26	BUY	6	105.430	107.860	107.617	USD 646	96.46
2024-11-21	BUY	30	105.870	106.990	106.878	USD 3,206	94.80
2024-11-20	BUY	18	103.440	104.110	104.043	USD 1,873	94.32
2024-11-18	BUY	72	103.550	104.610	104.504	USD 7,524	93.15
2024-11-12	BUY	48	103.260	105.780	105.528	USD 5,065	92.48
2024-11-08	BUY	30	104.250	104.810	104.754	USD 3,143	91.64
2024-11-07	BUY	90	101.070	103.290	103.068	USD 9,276	90.91
2024-11-06	BUY	12	101.710	103.960	103.735	USD 1,245	90.01
2024-10-31	BUY	6	88.390	89.340	89.245	USD 535	87.73

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of LMAT

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	48,133	0	86,111	55.9%
2025-09-18	33,733	2	45,351	74.4%
2025-09-17	19,522	0	28,339	68.9%
2025-09-16	72,014	0	81,278	88.6%
2025-09-15	133,219	0	144,797	92.0%
2025-09-12	14,273	0	22,993	62.1%
2025-09-11	25,498	0	38,811	65.7%
2025-09-10	33,299	1,163	56,231	59.2%
2025-09-09	15,538	0	27,406	56.7%
2025-09-08	25,084	195	35,746	70.2%
2025-09-05	39,294	0	49,195	79.9%
2025-09-04	51,153	3,071	74,925	68.3%
2025-09-03	37,834	0	44,726	84.6%
2025-09-02	34,673	90	49,099	70.6%
2025-08-29	16,280	19	27,957	58.2%
2025-08-28	24,937	0	44,398	56.2%
2025-08-27	27,760	0	43,718	63.5%
2025-08-26	201,569	0	237,350	84.9%
2025-08-25	37,784	221	87,848	43.0%
2025-08-22	29,055	0	45,323	64.1%
2025-08-21	120,796	0	140,414	86.0%
2025-08-20	70,592	0	120,937	58.4%
2025-08-19	24,740	1,000	45,911	53.9%
2025-08-18	18,461	0	37,197	49.6%
2025-08-15	72,273	5,178	90,275	80.1%
2025-08-14	44,275	0	72,798	60.8%
2025-08-13	13,505	0	25,348	53.3%
2025-08-12	38,979	0	95,899	40.6%
2025-08-11	46,872	9,552	99,741	47.0%
2025-08-08	27,433	2,475	52,285	52.5%
2025-08-07	71,111	5,837	97,137	73.2%
2025-08-06	80,804	0	119,774	67.5%
2025-08-05	78,750	0	115,887	68.0%
2025-08-04	42,686	25	67,818	62.9%
2025-08-01	29,396	0	45,224	65.0%
2025-07-31	25,326	0	36,168	70.0%
2025-07-30	17,903	2,020	28,211	63.5%
2025-07-29	19,086	2,062	26,591	71.8%
2025-07-28	19,014	0	29,841	63.7%
2025-07-25	30,116	34	39,747	75.8%
2025-07-24	20,148	0	33,746	59.7%
2025-07-23	21,739	0	35,103	61.9%
2025-07-22	23,312	2,447	33,015	70.6%
2025-07-21	19,745	0	32,991	59.8%
2025-07-18	22,151	0	35,523	62.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Note: All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE